United States· US:72789-131_2c2501a6-a6d6-1d6c-e063-6294a90ad428
Acarbose
A acarbose product containing acarbose, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Acarbose is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BF01 (acarbose), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Acarbose · ATC A10BF01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acarbose costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.52 in Spain to $1.01 in United States — a ×1.9 gap.
- United States: $1.01 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Acarbose · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$1.01 (acquisition cost)
- IT Italy$0.96
- FR France$0.65
- ES Spain$0.52
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Acarbose
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- A10BF01
- ATC class
- Acarbose
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 3
- ndc11727891313030 TABLET in 1 BOTTLE, PLASTIC (72789-131-30)
- ndc11727891316060 TABLET in 1 BOTTLE, PLASTIC (72789-131-60)
- ndc11727891319090 TABLET in 1 BOTTLE, PLASTIC (72789-131-90)
Regulatory notes
Interactions
461 interactions on record for acarbose.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acarbose · interactions on record
461 records
- 8 severe
- 262 moderate
- 46 minor
- 145 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- GatifloxacinJ01MA16severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acarbose in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAcarbose 100mg tabletsRivopharm (UK) Ltd
- CzechiaACARBOSE VIATRISVIATRIS LIMITED, Dublin
- FranceACARBOSE ARROW 100 mg, comprimé sécableARROW GENERIQUES
- SpainACARBOSA FARMALIDER 100 MG COMPRIMIDOSFarmalider S.A.
- ItalyACARBOSIO AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- GermanyAcarbose AbzAbz-Pharma Gmbh
- PolandAcarbose AurovitasAurovitas Pharma Polska Sp. z o.o.
- NorwayAcarbose alALUID PHARMA
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Ароба
- Czechia · Acarbose Viatris
- Germany · Acarbose Al, Acarbose Dura
- Spain · Acarbosa Farmalider, Acarbosa Qualigen
- France · Acarbose Arrow, Acarbose Arrow Lab
- United Kingdom (Northern Ireland) · Acarbose, Acarbose Generics [uk] Ltd
- Italy · Acarbosio Aurobindo, Acarbosio Doc Generici
- Poland · Acarbose Aurovitas, Adeksa
- Portugal · Acarbose Berar Laboratórios Basi - Indústria Farmacêutica, Acarbose Bluepharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb2dbe29-0465-4975-b3ed-0cf4225bb15f GET /v1/drugs/bb2dbe29-0465-4975-b3ed-0cf4225bb15f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "T58MSI464G",
"rxcui": "16681",
"inchikey": "CEMXHAPUFJOOSV-XGWNLRGSSA-N",
"display_name": "ACARBOSE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 2
},
"spl_meta": {
"d1b627e1-d78d-47dd-93f5-2bf4998466ba": {
"match": "brand_token",
"title": "ACARBOSE TABLET [CHARTWELL RX, LLC]",
"spl_version": "3",
"published_date": "2025-12-10"
}
},
"productid": "72789-131_2c2501a6-a6d6-1d6c-e063-6294a90ad428",
"productndc": "72789-131",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "078470",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "25MG",
"product_no": "001",
"approval_date": "May 7, 2008"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "50MG",
"product_no": "002",
"approval_date": "May 7, 2008"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "100MG",
"product_no": "003",
"approval_date": "May 7, 2008"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ACARBOSE",
"proprietary_name": "Acarbose",
"active_ingred_unit": "mg/1",
"application_number": "ANDA078470",
"marketing_category": "ANDA",
"nonproprietary_name": "Acarbose",
"start_marketing_date": "20080507",
"active_numerator_strength": "25"
}See everything about acarbose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.